Workflow
Analysts revise Lemonade (LMND) stock price targets
LMNDLemonade(LMND) Finbold·2024-11-24 13:08

Core Viewpoint - Lemonade, Inc. has gained significant attention following its strong Q3 2024 earnings and investor day updates, leading to revised price targets from analysts reflecting both optimism and caution regarding its high-risk profile [1][4]. Financial Performance - In Q3 2024, Lemonade reported a 24% year-over-year increase in in-force premium (IFP), reaching 889million,anda17889 million, and a 17% rise in customer count to 2.3 million [2]. - Revenue surged 71% to 136.6 million, while gross profit increased to 38million,representinga2738 million, representing a 27% gross profit margin [2]. - The company generated a positive net cash flow of 48 million, indicating improved financial health [2]. Loss and Risk Management - Lemonade posted a net loss of 67.7million,or67.7 million, or 0.95 per share, in Q3 2024, compared to a net loss of 61.5million,or61.5 million, or 0.88 per share, in Q3 2023 [3]. - The improved loss ratio of 81%, down from 88% last year, highlights progress in enhancing risk management capabilities [3]. Future Projections - Lemonade projects adjusted EBITDA profitability by 2026 and expects its IFP to reach 1.2billionbyFY2025[3].ForFY2024,thecompanyanticipatesitsinforcepremiumtobebetween1.2 billion by FY2025 [3]. - For FY2024, the company anticipates its in-force premium to be between 940 million and 944million,signalingcontinuedgrowthmomentum[3].AnalystPriceTargetsJPMorganraisedLemonadespricetargetto944 million, signaling continued growth momentum [3]. Analyst Price Targets - JP Morgan raised Lemonade's price target to 60 from 40,maintaininganOutperformrating,citingleadershipinAIadoptionandscalability[5].BMOCapitalraiseditstargetto40, maintaining an 'Outperform' rating, citing leadership in AI adoption and scalability [5]. - BMO Capital raised its target to 15 from 13,maintaininganUnderperformrating,adjustingitsvaluationapproachduetoalessdilutivecapitalraise[5].PiperSandlerlifteditstargetto13, maintaining an 'Underperform' rating, adjusting its valuation approach due to a less dilutive capital raise [5]. - Piper Sandler lifted its target to 44 from $25, retaining a Neutral rating, and noted expectations for free cash flow profitability by FY2024 and adjusted EBITDA breakeven by FY2026 [5].